Shares of Iambic Therapeutics Inc., an AI-powered biotechnology company backed by NVIDIA, surged 16% on its first day of trading after raising $150 million in its U.S. initial public offering (IPO). According to Bloomberg Markets, the company's stock trading was temporarily halted due to volatility before resuming trade at $18.50 per share, above its IPO price of $16.